Meta-hallmarks of aging and cancer

Both aging and cancer are characterized by a series of partially overlapping “hallmarks” that we subject here to a meta-analysis. Several hallmarks of aging (i.e., genomic instability, epigenetic alterations, chronic inflammation, and dysbiosis) are very similar to specific cancer hallmarks and henc...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cell metabolism 2023-01, Vol.35 (1), p.12-35
Hauptverfasser: López-Otín, Carlos, Pietrocola, Federico, Roiz-Valle, David, Galluzzi, Lorenzo, Kroemer, Guido
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Both aging and cancer are characterized by a series of partially overlapping “hallmarks” that we subject here to a meta-analysis. Several hallmarks of aging (i.e., genomic instability, epigenetic alterations, chronic inflammation, and dysbiosis) are very similar to specific cancer hallmarks and hence constitute common “meta-hallmarks,” while other features of aging (i.e., telomere attrition and stem cell exhaustion) act likely to suppress oncogenesis and hence can be viewed as preponderantly “antagonistic hallmarks.” Disabled macroautophagy and cellular senescence are two hallmarks of aging that exert context-dependent oncosuppressive and pro-tumorigenic effects. Similarly, the equivalence or antagonism between aging-associated deregulated nutrient-sensing and cancer-relevant alterations of cellular metabolism is complex. The agonistic and antagonistic relationship between the processes that drive aging and cancer has bearings for the age-related increase and oldest age-related decrease of cancer morbidity and mortality, as well as for the therapeutic management of malignant disease in the elderly. Cancer is an age-associated disease. López-Otín et al. discuss which hallmarks of aging coincide with the hallmarks of cancer and hence constitute meta-hallmarks explaining the time-dependent manifestation of malignancy. The authors also examine specific characteristics of the aging process that antagonize oncogenesis.
ISSN:1550-4131
1932-7420
DOI:10.1016/j.cmet.2022.11.001